Hims & Hers (HIMS) stock has crash more than 25% in recent sessions after Novo Nordisk (NVO) filed a sweeping patent-infringement lawsuit targeting the company’s semaglutide offerings. This legal punch follows a U.S. Food Read More
February 12, 2026